Search Results for 'Investment Management'
42 results found.
Luan Gallery is delighted to introduce Curator Rayne Booth for the autumn instalment of an ‘Artists Talk’ with artists Eoin Francis McCormack and Susanne Wawra. This event will take place on Saturday, August 25 at 2pm.
Quidel Corporation a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, celebrated opening its new Business Service Centre in Merchant’s Road in Galway city this week.
‘Fishing for Business Opportunities: Catch onto new strategies at Our Ocean Wealth Summit’
There is an “urgent need to have more industry developed” on industrial zoned land in Knocknacarra, a move that, if realised, would daily reduce traffic volumes in the area and increase local employment.
The campus at NUI Galway is to become the testbed for driverless cars, it was confirmed yesterday (Wednesday) when researchers from the Lero SFI Research Centre at the university signed an autonomous vehicles R&D partnership with Valeo, the major automotive supplier headquartered in Paris.
A digital marketing drive to attract inward investment into Mayo was launched by IDA Ireland yesterday at the newly completed Advance Technology Building (ATB) in Castlebar.
POETRY, THEATRE, and art will all be on the bill at the Galway Arts Centre's first event of 2018 - Oíche Nollaig na mBan - which will celebrate the work of female artists and mark the official end of the festive season.
US Pharmaceutical Company, Aerie Pharmaceuticals, is to establish its first manufacturing plant in Athlone’s Technology & Business Park with an initial investment of €55m. Some 80 jobs will be created at the plant.
US pharmaceutical Company, Aerie Pharmaceuticals, Inc. is to establish its first manufacturing plant in Athlone’s Technology & Business Park. Headquartered in California, with locations in New Jersey, North Carolina, Aerie has also established an Irish entity in Dublin, Aerie Pharmaceuticals Ireland Ltd. Aerie is a clinical stage pharmaceutical company focused on the discovery, development and commercialisation of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.